An Inside Look at the CNS
CSF cytokine profiling can offer a faster, less invasive way to distinguish between cancer, infections, and autoimmune processes in the brain
Danielle Fortuna, Mark Curtis |
At a Glance
- Current tests for problems of the brain and spine can be invasive or require significant time investment to obtain results
- Patients with neurological symptoms often can’t wait for an answer – so they’re treated based on early evidence
- CSF cytokine profiling is rapid and performed on spinal fluid samples routinely obtained from patients with serious CNS disorders
- Performing such a procedure early in a patient’s presentation can optimize treatment and spare the patient unnecessary additional tests
A patient presents with neurological symptoms – perhaps headache, numbness, or functional difficulties. It’s clear that this is an urgent situation, but the patient obviously can’t be treated appropriately without knowing the underlying cause of their symptoms. But even the most basic questions – for example, “Is the problem a brain infection or cancer?” – can be time-consuming and require a brain biopsy to answer.
Read the full article now
Log in or register to read this article in full and gain access to The Translational Scientist’s entire content archive. It’s FREE and always will be!